Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Social isolation during adolescence alters novel object recognition memory, brain and gut gene expression, and microbiota composition in a sex-specific manner.
Effect of nerolidol on seizure and oxidative brain damage induced by pentylenetetrazole in mice.
Temporal changes in metabolism guide oligodendrocyte precursor cell dynamics in aging and multiple sclerosis.
Maintenance intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: trends from an Australian tertiary centre.
Significance of Phrenic Nerve Conduction Study in the Electrodiagnosis of Guillain Barré Syndrome.
Microglial states associate with lesion dynamics in multiple sclerosis.
Optic Neuritis in the Puerperium Mimicking Severe Preeclampsia: A Neurological Differential Diagnosis in the Obstetric Emergency Setting.
Efficacy and Safety of Cannabis Derivates and Their Synthetic Analogs. Overview of Systematic Reviews.
Metabolic Pathways and Molecular Regulatory Mechanisms of Nervonic Acid Biosynthesis in .
Building Towards Initiation, Moderation, De-Escalation and Cessation of Disease-Modifying Treatments for Multiple Sclerosis in Greece: An Expert Panel Consensus Meeting.
Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.
Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes.
The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.
Genetic Prognostic Factors in Multiple Sclerosis: Key Discoveries and Unmet Needs.
Auditory Stimulation of Slow-Wave Sleep Promotes Recovery after Brain Injury in an Animal Model.
Modifiable risk factors and their joint impact on late-onset multiple sclerosis: Evidence from the UK Biobank.
Hmgcs1 regulates cholesterol synthesis and promotes nerve fiber repair after spinal cord injury.
Adjunctive Non-Disease-Modifying Therapies in Multiple Sclerosis: Immunometabolic, Neuroprotective and Remyelination-Oriented Approaches.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Electrochemical aptasensing reveals serum myelin alterations in diabetic neuropathy.
Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
An adaptive cellular source of IL-17A and IL-17F is critical for the induction of experimental autoimmune encephalomyelitis.
C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications.
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.
Cerebrospinal Fluid sCD27 as a Biomarker of Neuroinflammatory Disease: A Systematic Review and Meta-Analysis.

Pages